1. Home
  2. CHRS vs LSBK Comparison

CHRS vs LSBK Comparison

Compare CHRS & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRS
  • LSBK
  • Stock Information
  • Founded
  • CHRS 2010
  • LSBK 1891
  • Country
  • CHRS United States
  • LSBK United States
  • Employees
  • CHRS N/A
  • LSBK N/A
  • Industry
  • CHRS Biotechnology: Biological Products (No Diagnostic Substances)
  • LSBK Savings Institutions
  • Sector
  • CHRS Health Care
  • LSBK Finance
  • Exchange
  • CHRS Nasdaq
  • LSBK Nasdaq
  • Market Cap
  • CHRS 94.0M
  • LSBK 90.3M
  • IPO Year
  • CHRS 2014
  • LSBK 2006
  • Fundamental
  • Price
  • CHRS $0.91
  • LSBK $15.97
  • Analyst Decision
  • CHRS Strong Buy
  • LSBK
  • Analyst Count
  • CHRS 4
  • LSBK 0
  • Target Price
  • CHRS $5.38
  • LSBK N/A
  • AVG Volume (30 Days)
  • CHRS 2.1M
  • LSBK 4.9K
  • Earning Date
  • CHRS 05-08-2025
  • LSBK 04-21-2025
  • Dividend Yield
  • CHRS N/A
  • LSBK 4.51%
  • EPS Growth
  • CHRS N/A
  • LSBK 6.97
  • EPS
  • CHRS 0.25
  • LSBK 0.88
  • Revenue
  • CHRS $266,959,999.00
  • LSBK $25,846,000.00
  • Revenue This Year
  • CHRS N/A
  • LSBK N/A
  • Revenue Next Year
  • CHRS $9.02
  • LSBK N/A
  • P/E Ratio
  • CHRS $3.66
  • LSBK $18.06
  • Revenue Growth
  • CHRS 3.78
  • LSBK N/A
  • 52 Week Low
  • CHRS $0.66
  • LSBK $10.30
  • 52 Week High
  • CHRS $2.61
  • LSBK $16.95
  • Technical
  • Relative Strength Index (RSI)
  • CHRS 45.16
  • LSBK 49.59
  • Support Level
  • CHRS $0.89
  • LSBK $15.71
  • Resistance Level
  • CHRS $1.07
  • LSBK $16.12
  • Average True Range (ATR)
  • CHRS 0.09
  • LSBK 0.26
  • MACD
  • CHRS -0.00
  • LSBK -0.05
  • Stochastic Oscillator
  • CHRS 44.79
  • LSBK 6.17

About CHRS Coherus BioSciences Inc.

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and, to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

Share on Social Networks: